Skip to content
Search

Latest Stories

Lo’s Pharmacy set to launch innovative hub and spoke model

Lo’s Pharmacy, a Yorkshire-based pharmacy chain is adopting a new approach to hub and spoke in a first of a kind model to be used in the UK.

The pharmacy will centralise its repeat prescription dispensing service for original packs with the support of its medication wholesaler.


The independent group, which has 25 NHS community pharmacies across Yorkshire, will install Centred Solution’s Automated FLOWRx Hub product at its central dispensing facility in Wath-Upon-Dearne, South Yorkshire.

But unlike other FLOWRx customers, who pick packs from a robotic dispensing system or internal warehouse, Lo’s Pharmacy will receive patient-specific flow totes directly from their wholesaler which can then be processed by their hub.

This workflow has not been used anywhere else in the country until now and it is a revolutionary approach to hub and spoke dispensing, showing what can be achieved when key players decide to collaborate. It further demonstrates that there are range of variations of hub and spoke models available and accessible to independent and multiple community pharmacies across the UK.

How the solution will work

Branch pharmacies will perform the clinical and accuracy check and transmit a hub order for patients’ prescriptions using FLOWRx Instore directly to Lo’s Pharmacy’s preferred wholesaler. The wholesaler will then process the order and create patient-specific flow totes containing the exact amount of medication for a specific number of patients.

These patient-specific totes, filled with loose medications, will then be delivered to Lo’s Pharmacy hub where the tote will be scanned and then processed through the FLOWRx automatic labelling unit which scans the medication pack, assigns it for the correct patient and then automatically labels the pack. The medication will be processed into allocated patient baskets at a sortation station before being bagged, scanned and placed into branch totes ready to be delivered back to the pharmacy spoke.

Barcode and RFID technology adds additional safety checks to ensure the right pack is processed for the right patient. Any anomalies are flagged by the system and baskets are placed into a quarantine state where they must be checked and cleared by a pharmacist or ACT before they can continue to be processed.

Back at the pharmacy spoke, FLOWRx Instore will be used to process any exceptions that could not be dispensed at the hub, for example fridge items and controlled drugs, before the prescription is then dispensed to the patient.

An exciting new venture

“When we were looking to move to a hub and spoke model we knew we had to find the right workflow for our pharmacy group. We have worked closely with both Centred Solutions and our medication wholesaler to make our vision a reality and we are excited to be the first pharmacy group in the UK to run with this particular hub and spoke model,” said William Kong, Commercial Manager for Lo’s Pharmacy Group.

“We are confident that the hub and spoke model we are putting in place will free up our branch staff from logistical back room tasks so that they have more time to spend at the counter with patients or in the consulting room delivering both NHS and private services,” he said.

Paul O’Hanlon, Managing Director at Centred Solutions said: “It’s great to see Lo’s Pharmacy embracing hub and spoke and implementing a different workflow to our existing customers. No pharmacy is ever the same and so a one-size fits all approach is never going to work. We pride ourselves on having bespoke software and automation available to meet the differing needs of different pharmacy groups. This is yet another example of hub and spoke being a realistic and achievable option for pharmacies of all shapes and sizes.”

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less